中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 近代物理研究所
  3. 中国科学院近代物理研究所
Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta-analysis

文献类型：期刊论文

作者Li, Zheng1,2,3,4; Li, Qiang1,2,3,5; Wang, Xiaohu3,4; Chen, Weiqiang1,2,3,5; Jin, Xiaodong1,2,3,5; Liu, Xinguo1,2,3,5; Ye, Fei1,2,3,5; Dai, Zhongying1,2,3,5; Zheng, Xiaogang1,2,3,5; Li, Ping1,2,3,5
刊名CANCER MEDICINE
出版日期2021-10-16
页码19
ISSN号2045-7634
关键词COVID-19 hepatocellular carcinoma hyperthermia ablation meta-analysis SARS-CoV-2 transarterial chemoembolization
DOI10.1002/cam4.4350
通讯作者Li, Qiang(liqiang@impcas.ac.cn)
英文摘要Background and aims The existing evidence has indicated that hyperthermia ablation (HA) and HA combined with transarterial chemoembolization (HATACE) are the optimal alternative to surgical resection for patients with hepatocellular carcinoma (HCC) in the COVID-19 crisis. However, the evidence for decision-making is lacking in terms of comparison between HA and HATACE. Herein, a comprehensive evaluation was performed to compare the efficacy and safety of HATACE with monotherapy. Materials and Methods Worldwide studies were collected to evaluate the HATACE regimen for HCC due to the practical need for global extrapolation of applicative population. Meta-analyses were performed using the RevMan 5.3 software (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark). Results Thirty-six studies involving a large sample of 5036 patients were included finally. Compared with HA alone, HATACE produced the advantage of 5-year overall survival (OS) rate (OR:1.90; 95%CI:1.46,2.46; p < 0.05) without increasing toxicity (p >= 0.05). Compared with TACE alone, HATACE was associated with superior 5-year OS rate (OR:3.54; 95%CI:1.96,6.37; p < 0.05) and significantly reduced the incidences of severe liver damage (OR:0.32; 95%CI:0.11,0.96; p < 0.05) and ascites (OR:0.42, 95%CI:0.20,0.88; p < 0.05). Subgroup analysis results of small (<= 3 cm) HCC revealed that there were no significant differences between the HATACE group and HA monotherapy group in regard to the OS rates (p >= 0.05). Conclusions Compared with TACE alone, HATACE was more effective and safe for HCC. Compared with HA alone, HATACE was more effective for non-small-sized (>3 cm) HCC with comparable safety. However, the survival benefit of adjuvant TACE in HATACE regimen was not found for the patients with small (<= 3 cm) HCC.
WOS关键词TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION ; RADIOFREQUENCY ABLATION ; MICROWAVE ABLATION ; COMBINED THERAPY ; COMBINATION THERAPY ; CLINICAL CHARACTERISTICS ; SURGICAL RESECTION ; THERMAL ABLATION ; CANCER-TREATMENT ; RISK-FACTORS
资助项目China Postdoctoral Science Foundation[2019M663860] ; National Key Research Program of China[2018YFC0115700] ; National Key Research Program of China[2018YFC0115702] ; National Natural Science Foundation of China[11875299] ; National Natural Science Foundation of China[U1532264] ; Key Deployment Project of Chinese Academy of Sciences[SW--222] ; West Light Foundation of Chinese Academy of Sciences[29Y86205]
WOS研究方向Oncology
语种英语
出版者WILEY
WOS记录号WOS:000707557000001
资助机构China Postdoctoral Science Foundation ; National Key Research Program of China ; National Natural Science Foundation of China ; Key Deployment Project of Chinese Academy of Sciences ; West Light Foundation of Chinese Academy of Sciences
源URL[http://119.78.100.186/handle/113462/136210]  
专题中国科学院近代物理研究所
通讯作者Li, Qiang
作者单位1.Gansu Prov Key Lab Basic Res Heavy Ion Radiat App, Lanzhou, Peoples R China
2.Chinese Acad Sci, Key Lab Heavy Ion Radiat Biol & Med, Lanzhou, Peoples R China
3.Chinese Acad Sci, Inst Modern Phys, 509 Nanchang Rd, Lanzhou 730000, Peoples R China
4.Lanzhou Heavy Ion Hosp, Lanzhou, Peoples R China
5.Univ Chinese Acad Sci, Beijing, Peoples R China
推荐引用方式
GB/T 7714		 Li, Zheng,Li, Qiang,Wang, Xiaohu,et al. Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta-analysis[J]. CANCER MEDICINE,2021:19.
APA Li, Zheng.,Li, Qiang.,Wang, Xiaohu.,Chen, Weiqiang.,Jin, Xiaodong.,...&Liu, Ruifeng.(2021).Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta-analysis.CANCER MEDICINE,19.
MLA Li, Zheng,et al."Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta-analysis".CANCER MEDICINE (2021):19.

入库方式： OAI收割

来源：近代物理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。